Search for: "Amgen Inc. v. Sandoz"
Results 81 - 100
of 112
Sorted by Relevance
|
Sort by Date
17 Feb 2017, 12:21 pm
Amgen and Amgen v. [read post]
3 Jun 2016, 6:40 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
30 Sep 2015, 4:30 am
Amgen, Inc., et al., Case No. 2:12-cv-476 (M.D. [read post]
22 Sep 2022, 9:54 am
Sandoz, which produces a biosimilar sold outside of the US called Erelzi, attempted to invalidate the patents, taking their case all the way to the Supreme Court (Sandoz Inc. v Immunex Corp., 20-1110, Supreme Court). [read post]
20 Jun 2016, 10:20 am
Sandoz and Sandoz v. [read post]
1 Apr 2016, 8:22 am
First Quality Baby Products, LLC, et al., No. 15-927 (three amici filed in support) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
28 Jun 2016, 6:41 am
(post-sale restrictions); and Sandoz v. [read post]
24 Aug 2012, 4:33 pm
Relying on our decision in Amgen Inc. v. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
14 Jun 2017, 4:18 am
Sandoz Inc. [read post]
3 May 2016, 1:42 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
18 May 2016, 8:19 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
17 Mar 2016, 2:45 am
First Quality Baby Products, LLC, et al., No. 15-927 (three amici filed in support) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
15 Apr 2010, 4:27 am
Sandoz B.V. [read post]
12 Jan 2017, 7:01 am
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
27 Aug 2012, 9:31 am
Relying on Amgen Inc. v. [read post]
